Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rank in Stocks
#4957
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Share Price
$2.47
Market Cap
$2.95B
Change (1 day)
-1.22%
Change (1 year)
-14.21%
Country
CN
Trade Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Category
Healthcare
P/S ratio for Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
P/S ratio as of October 2026 TTM: 9.16
According to Jilin Aodong Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.16. At the end of 2023 the company had a P/S ratio of 4.95.
P/S ratio history for Jilin Aodong Pharmaceutical Group Co., Ltd. from 2000 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 9.16 | 17.55% |
| 2024 | 7.79 | 57.42% |
| 2023 | 4.95 | -16.58% |
| 2022 | 5.93 | -35.08% |
| 2021 | 9.14 | 7.82% |
| 2020 | 8.47 | 36.12% |
| 2019 | 6.22 | 23.83% |
| 2018 | 5.03 | -43.06% |
| 2017 | 8.83 | -11.71% |
| 2016 | 10.00 | -15.67% |
| 2015 | 11.86 | -14.55% |
| 2014 | 13.88 | 70.41% |
| 2013 | 8.14 | -22.90% |
| 2012 | 10.56 | -13.66% |
| 2011 | 12.23 | -30.20% |
| 2010 | 17.52 | -36.38% |
| 2009 | 27.55 | 138.21% |
| 2008 | 11.56 | -74.15% |
| 2007 | 44.73 | 263.35% |
| 2006 | 12.31 | 492.21% |
| 2005 | 2.08 | 6.97% |
| 2004 | 1.94 | -2.21% |
| 2003 | 1.99 | -38.79% |
| 2002 | 3.25 | -45.50% |
| 2001 | 5.96 | -42.80% |
| 2000 | 10.41 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -22.92% |
IN
|
